African AIDS Vaccine Programme for a coordinated and collaborative vaccine development effort on the continent
2008

African AIDS Vaccine Programme for Coordinated Vaccine Development

publication Evidence: moderate

Author Information

Author(s): Pontiano Kaleebu, Abimiku Alash'le, El-Halabi Shenaaz, Koulla-Shiro Sinata, Mamotte Nicole, Mugerwa Roy, Nkengasong John, Toure-Kane Coumba, Tucker Tim, Wassenaar Douglas, Williamson Carolyn, Wolday Dawit

Hypothesis

The African AIDS Vaccine Programme aims to mobilize support for an Africa-focused HIV vaccine agenda.

Conclusion

The African AIDS Vaccine Programme has significantly increased visibility and collaboration among African HIV vaccine stakeholders.

Supporting Evidence

  • AAVP was created in 2000 to address the lack of attention to Africa's need for an HIV vaccine.
  • The programme has successfully raised funds and increased training in HIV vaccine development.
  • AAVP has facilitated collaborations and training programs among African HIV vaccine stakeholders.

Takeaway

The African AIDS Vaccine Programme is a group of people in Africa working together to create a vaccine for HIV, which is a big problem in their communities.

Methodology

The paper describes the formation, mission, and activities of the African AIDS Vaccine Programme.

Digital Object Identifier (DOI)

10.1371/journal.pmed.0050236

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication